In mid-March, Aurora Cannabis (ACB) hit a 52-week low of $0.60 per share, with some commentators believing it hadn’t hit bottom yet.

Although the news about CytoDyn (CYDY) saying it could probably adapt its leronlimab drug to battle COVID-19, is two weeks old, the media …

One of the things that has attracted me to Aurora Cannabis (ACB) for some time has been its decision to forego giving up …

In 2019, in the cannabis sector, Aphria (APHA) was one of the bright spots in a mostly dismal year for most of its …

Hexo (HEXO) stock hasn’t been getting a lot of love from the market or analysts lately, as it has plummeted over 80% from …

The latest earnings report of Aurora Cannabis (ACB) came in as expected, with results confirming a weak quarter for the company. While the …

Aurora Cannabis (ACB) announced it was going to cut 500 jobs, with 25 percent of them being corporate positions, while taking impairment charges …

With so many headwinds facing Nio Inc. (NIO), it’s surprising that shares have managed to stay afloat.

Charlotte’s Web (CWBHF) is one of the most recognizable brands in the cannabis sector anywhere in the world, and it has garnered a …

I remain bullish on Aurora Cannabis (ACB) over the long term, as the company improves its cost structure while positioning itself to drive …